Epithelial-mesenchymal transition and its regulators are major targets of triple-negative breast cancer

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Triple negative breast cancer (TNBC) is an aggressive subtype characterized by early recurrence and poor prognosis.
• c-Met receptor tyrosine kinase is overexpressed in approximately 52% of TNBC cases.
• c-Met signaling is implicated in initiating epithelial-mesenchymal transition (EMT), a critical process for cancer cell metastasis.

Purpose of the Study:

• To explore the association between c-Met overexpression and EMT in triple negative breast cancer.
• To highlight the role of c-Met signaling in the metastatic progression of TNBC.
• To provide a concise overview of current understanding regarding c-Met and EMT in TNBC.

Main Methods:

• Literature review and synthesis of existing research on c-Met, EMT, and TNBC.
• Analysis of studies reporting c-Met expression levels in TNBC patient cohorts.
• Examination of experimental evidence linking c-Met signaling to EMT pathways.

Main Results:

• Significant overexpression of c-Met is frequently observed in TNBC.
• c-Met activation promotes EMT, enhancing cancer cell motility and invasiveness.
• The c-Met/EMT axis is a key driver of metastatic progression in TNBC.

Conclusions:

• The c-Met pathway plays a critical role in the aggressive phenotype and metastatic potential of TNBC.
• Targeting c-Met signaling represents a potential therapeutic strategy to inhibit EMT and metastasis in TNBC.
• Further research into the c-Met/EMT interaction is warranted for developing effective treatments for TNBC.